Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuxian Wei
Observed names:
Y. Wei,
YUXIAN WEI,
Yu-Xian Wei,
Yu-xian Wei,
Yu‐Xian Wei
Institution:
The Affiliated Yongchuan Hospital of Chongqing Medical University
Observed institutions:
Shanghai Medical College of Fudan University,
Minzu University of China,
Fudan University,
Zhongshan Hospital,
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Chongqing Medical University
show all 6
ORCID:
0000-0002-6900-5550
Observed ORCID:
0000-0002-6900-5550
OpenAlex ID:
A5109461503
FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts
2022
·
Yushen Wu
, Ziying Yi
, et al.
·
Theranostics
·
133
PDF
Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy
2024
·
Daqiang Song
, Yushen Wu
, et al.
·
Journal of Clinical Investigation
·
68
PDF
Reprogramming exosomes for immunity-remodeled photodynamic therapy against non-small cell lung cancer
2024
·
Jiao Guo
, Wei Zhao
, et al.
·
Bioactive Materials
·
60
Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer
2016
·
Xuedong Yin
, Tingxiu Xiang
, et al.
·
Oncotarget
·
60
PDF
Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis
2023
·
Yuru Chen
, Jiazheng Sun
, et al.
·
Journal for ImmunoTherapy of Cancer
·
44
PDF
NLRP1 Overexpression Is Correlated with the Tumorigenesis and Proliferation of Human Breast Tumor
2017
·
Yuxian Wei
, Hongyan Huang
, et al.
·
BioMed Research International
·
42
PDF
Comparison of epidemiological features, clinicopathological features, and treatments between premenopausal and postmenopausal female breast cancer patients in western China: a retrospective multicenter study of 15,389 female patients
2018
·
Fan Feng
, Yuxian Wei
, et al.
·
Cancer Medicine
·
29
PDF
Echinacoside inhibits tumor immune evasion by downregulating inducible PD-L1 and reshaping tumor immune landscape in breast and colorectal cancer
2024
·
Xiaoyu Wang
, Binxin Tan
, et al.
·
Phytomedicine
·
24
AEBP1 drives fibroblast-mediated T cell dysfunction in tumors
2025
·
Xiaoyu Wang
, Jie Li
, et al.
·
Nature Communications
·
18
PDF
Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China: a retrospective multi-center study of 7317 female patients
2017
·
Ke Zheng
, Jin-Xiang Tan
, et al.
·
Breast Cancer Research and Treatment
·
18
ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer
2021
·
Jiazhou Liu
, Yuxian Wei
, et al.
·
Frontiers in Immunology
·
17
PDF
Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials
2019
·
Zhou Xu
, Feng Luo
, et al.
·
Cancer Chemotherapy and Pharmacology
·
16
Acetylation-dependent deubiquitinase USP26 stabilizes BAG3 to promote breast cancer progression
2024
·
Jiazhou Liu
, Mo Zhai
, et al.
·
Cancer Letters
·
15
Relationship between social support and self‐care ability among patients with breast cancer during rehabilitation: The multiple mediating roles of resilience and depression
2024
·
Xiu‐Ying Tang
, Yu‐Xian Wei
, et al.
·
Journal of Clinical Nursing
·
14
PDF
Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas
2024
·
Daqiang Song
, Qian Yang
, et al.
·
Frontiers in Immunology
·
13
The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects
2022
·
Xingjia Lu
, Jian Zhong
, et al.
·
Frontiers in Oncology
·
13
PDF
An immune-related prognostic gene ULBP2 is correlated with immunosuppressive tumor microenvironment and immunotherapy in breast cancer
2023
·
Rui Feng
, Jiali Xu
, et al.
·
Heliyon
·
12
The prevalence and clinicopathological features of breast cancer patients with hepatitis B virus infection in China
2017
·
He Wu
, Chunxia Zhao
, et al.
·
Oncotarget
·
12
PDF
Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy
2024
·
Jiazheng Sun
, Pin Wang
, et al.
·
Cancer Immunology Research
·
11
The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy
2022
·
Jiazhou Liu
, Xiaoyu Wang
, et al.
·
Frontiers in Cell and Developmental Biology
·
11
PDF
Main complications and results of treatment with intra-arterial infusion chemotherapy through the subclavian and thoracic arteries for locally advanced breast cancer
2013
·
XIAOYI WANG
, CHANGING GAN
, et al.
·
Molecular and Clinical Oncology
·
11
PDF
Inorganic and organic hybrid nanoarchitectonics for biomedical application
2025
·
Xiaoming Zhang
, Zhanyao Xu
, et al.
·
Advances in Colloid and Interface Science
·
9
The expression and biological function of the PHF2 gene in breast cancer
2018
·
Lu Zhang
, Tian-Li Hui
, et al.
·
RSC Advances
·
8
PDF
Research progress on RNA‑binding proteins in breast cancer (Review)
2022
·
Wenzhu Zhang
, Linlin Liu
, et al.
·
Oncology Letters
·
7
PDF
A Ribosome-Related Prognostic Signature of Breast Cancer Subtypes Based on Changes in Breast Cancer Patients’ Immunological Activity
2023
·
Tiankuo Luan
, Daqiang Song
, et al.
·
Medicina
·
5
PDF
Show more works
View as search
Works count:
57
Citation count:
685
H-index:
14
I10-index:
21
Year
Topic
Type